Mar 13 |
Solid Biosciences files $300M mixed securities shelf
|
Mar 13 |
Solid Biosciences reports Q4 results
|
Mar 13 |
Solid Biosciences Provides Fourth Quarter and Full-Year 2023 Business Update and Financial Results
|
Mar 7 |
Solid Biosciences signs agreement with Armatus Bio for AAV-SLB101
|
Mar 7 |
Solid Biosciences Announces Licensing Agreement with Armatus Bio for the Use of AAV-SLB101, a Proprietary, Muscle-Targeted Capsid, in the Development of an RNAi Therapy to treat FSHD
|
Mar 6 |
Solid Biosciences to Participate at Upcoming Investor Conferences
|
Feb 29 |
14 Stocks With Heavy Insider Buying In 2024
|
Feb 15 |
Top 4 Health Care Stocks You May Want To Dump In February
|
Jan 31 |
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
|
Jan 30 |
Solid Biosciences files to sell 19.69M common shares for holders
|